The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Post hoc analysis of rashes reported in patients (pts) with BRAF-altered relapsed/refractory (r/r) pediatric low-grade glioma (pLGG) treated with the type II RAF inhibitor tovorafenib in FIREFLY-1.
 
Olaf Witt
Honoraria - Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; BMS; Day One Therapeutics; Janssen Research & Development (Inst); Merck KGaA; Novartis; Roche; SK Life Sciences
Research Funding - AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb/Ono Pharmaceutical (Inst); Day One Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Research & Development (Inst); Lilly (Inst); Loxo (Inst); Loxo/Bayer (Inst); Novartis (Inst); PreComb Therapeutics (Inst); Roche Pharma AG (Inst)
 
Susan Chi
Consulting or Advisory Role - Blueprint Medicines; Bristol-Myers Squibb/Roche; Epizyme
Travel, Accommodations, Expenses - Epizyme
 
Hyoung Jin Kang
Consulting or Advisory Role - Cartexell; GPCR Therapeutics; Jazz Pharmaceuticals; Novartis; Takeda
 
David Ziegler
Consulting or Advisory Role - Accendatech; Alexion Pharmaceuticals; Amgen; AstraZeneca/Merck; Bayer; Day One Biopharmaceuticals; FivePhusion; Norgine; Novartis
Research Funding - Accendatech (Inst)
Travel, Accommodations, Expenses - Bayer
 
Patricia Baxter
Research Funding - Bristol-Myers Squibb (Inst); Day One Therapeutics (Inst); Novartis (Inst)
 
Simon Bailey
No Relationships to Disclose
 
Pablo Hernáiz Driever
Consulting or Advisory Role - Alexion Pharmaceuticals (Inst); Bayer (Inst); Ipsen
 
Sarah Leary
Research Funding - Day One Therapeutics (Inst); E.R. Squibb Sons, LLC (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); PTC Therapeutics (Inst); Regeneron (Inst)
 
Geoffrey McCowage
Research Funding - Day One Biopharmaceuticals (Inst)
 
Sébastien Perreault
Leadership - Bayer
Stock and Other Ownership Interests - Day One Therapeutics; novocure
Honoraria - Bayer
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer
Expert Testimony - Bayer
 
Angela Waanders
Research Funding - Day One Biopharmaceuticals (Inst)
 
Daniel Landi
Speakers' Bureau - Day One Biopharmaceuticals
 
Lindsay Kilburn
Employment - Children's National Hospital; Kaiser Permanente (I)
Stock and Other Ownership Interests - Onconova Therapeutics (I)
Consulting or Advisory Role - Blueprint Medicines
Research Funding - Chimerix (Inst); Day One Biopharmaceuticals (Inst); Novartis (Inst); Recursion Pharmaceuticals (Inst); Regeneron (Inst); SonaCare Medical (Inst); SpringWorks Therapeutics (Inst)
 
Jordan Hansford
Leadership - SERVIER (Inst)
Stock and Other Ownership Interests - Anteotech
Consulting or Advisory Role - Alexion Pharmaceuticals
 
Dong-Anh Khuong-Quang
No Relationships to Disclose
 
Karsten Nysom
Consulting or Advisory Role - Lilly
 
Ashley Bailey-Torres
Employment - Day One Biopharmaceuticals
Stock and Other Ownership Interests - Day One Biopharmaceuticals
 
Jiaheng Qiu
Employment - Day One Biopharmaceuticals
Stock and Other Ownership Interests - Day One Biopharmaceuticals
 
Lisa McLeod
Employment - Day One Biopharmaceuticals
Stock and Other Ownership Interests - Day One Biopharmaceuticals
 
Jasper van der Lugt
No Relationships to Disclose